Uploaded August 2023 | Updated September 2026, 1 week ago
Mariano Garcia Blanco, MD, PhD
Professor, Department of Microbiology, Immunology, and Cancer Biology
Transcript:
Lately in society, we've been challenged by an RNA virus and we've solved the problem with an RNA vaccine and among RNA biologists. So what a better time to be an RNA biologist than right now. Love what I do and I love coming to work every morning and it is exciting to be able to do discoveries and also to apply them.
I'm Mariano Garcia Blanco. I am a professor and chair of Microbiology, Immunology and Cancer Biology here at University of Virginia. My laboratory works on two areas of RNA biology, both very important for human health. The first area is RNA viruses. The second area is autoimmune diseases and the RNA virus site of the lab. We've done work that identifies targets for new antivirals and that gives new ideas for vaccines against these viruses and the autoimmune disease side of it, we discover a completely novel pathway that we believe could be the target for new therapeutics that would be much better than what we currently have.
We believe these are all RNA based therapies that these can be a terrific addition to the Manning Institute of Biotechnology.
Mariano Garcia Blanco, MD, PhD
Professor, Department of Microbiology, Immunology, and Cancer Biology
Transcript:
Lately in society, we've been challenged by an RNA virus and we've solved the problem with an RNA vaccine and among RNA biologists. So what a better time to be an RNA biologist than right now. Love what I do and I love coming to work every morning and it is exciting to be able to do discoveries and also to apply them.
I'm Mariano Garcia Blanco. I am a professor and chair of Microbiology, Immunology and Cancer Biology here at University of Virginia. My laboratory works on two areas of RNA biology, both very important for human health. The first area is RNA viruses. The second area is autoimmune diseases and the RNA virus site of the lab. We've done work that identifies targets for new antivirals and that gives new ideas for vaccines against these viruses and the autoimmune disease side of it, we discover a completely novel pathway that we believe could be the target for new therapeutics that would be much better than what we currently have.
We believe these are all RNA based therapies that these can be a terrific addition to the Manning Institute of Biotechnology.
